序号 |
标题 |
次数 |
作者 |
发布时间 |
70651 |
Meso-5,10,15,20-四(对氯苯基)卟啉;TP-ClPPH2 |
106 |
WYQ |
2024-12-25 |
70652 |
Resveratrol Liposome 白藜芦醇脂质体 |
218 |
axc |
2024-12-25 |
70653 |
Zn-5,10,15,20-四(4-羧基苯基)卟啉(TCPP-Zn) |
121 |
WYQ |
2024-12-25 |
70654 |
Methyltetrazine-CH2NHCO-PEG6-CH2CH2COOH |
114 |
zyl |
2024-12-25 |
70655 |
ld-Ph-amido-PEG1-C2-NHS ester, 2101206-80-6,抗体- 药物偶联物 |
78 |
hyy |
2024-12-25 |
70656 |
cas:1807521-07-8,2,5-dioxopyrrolidin-1-yl 3-(2-(2-(4-formylbenzamido)ethoxy)ethoxy)propanoate |
64 |
h |
2024-12-25 |
70657 |
四价锰四苯基卟啉配合物,[XMnⅣ)TPP]2O(X=N3-或OCN-) |
96 |
WYQ |
2024-12-25 |
70658 |
Methyltetrazine-CH2NHCO-PEG11-CH2-C≡CH的结构式 |
72 |
zyl |
2024-12-25 |
70659 |
cas:126695-58-7,4-Azido-2,3,5,6-tetrafluorobenzoic Acid N-Succinimidyl ester |
67 |
h |
2024-12-25 |
70660 |
5,10,15,20-四-(对-十二酰氧基)苯基卟啉 (TLPPH2) |
74 |
WYQ |
2024-12-25 |
70661 |
cas:850180-76-6,3-azidopropanoate-N-hydroxysuccinimide ester |
88 |
h |
2024-12-25 |
70662 |
Methyltetrazine-CH2NHCO-PEG6-CH2-C≡CH的介绍 |
105 |
zyl |
2024-12-25 |
70663 |
cas:906564-59-8,5-Hexynoic Acid-NHS Ester |
75 |
h |
2024-12-25 |
70664 |
mPEG5-OCH2CH2COOH;甲氧基五聚乙二醇丙酸 |
120 |
wyh |
2024-12-25 |
70665 |
5-[4-(3,5-二-十二烷氧基苯甲酰亚胺基)苯基]-10,15,20-三苯基卟啉配体(DDTPP) |
75 |
WYQ |
2024-12-25 |
70666 |
cas:55750-62-4,3-(Maleimido)propionic acid N-hydroxysuccinimide ester |
119 |
h |
2024-12-25 |
70667 |
Meso-四(4-十四氨基甲酰苯基)卟啉(14AFPP) |
79 |
WYQ |
2024-12-25 |
70668 |
mPEG12-OH , 甲氧基十二聚乙二醇-羟基 |
110 |
wyh |
2024-12-25 |
70669 |
cas:1305053-43-3,15-(2-pyridyldithio)-4,7,10,13-tetraoxapentadecanoic acid N-hydroxysuccinimide ester |
64 |
h |
2024-12-25 |
70670 |
4-甲酰苯甲酸N-琥珀酰亚胺酯,60444-78-2,ADC试剂 |
95 |
hyy |
2024-12-25 |
70671 |
Meso-5,10,15,20-四(对氯苯基)卟啉;TP-ClPPH2 |
99 |
WYQ |
2024-12-25 |
70672 |
cas:317331‐86‐5,N-succinimidyl-5-(2-pyridyldithio)valerate |
71 |
h |
2024-12-25 |
70673 |
cas:663599-11-9,1-(4-((3-(dimethylcarbamoyl)pyridin-4-yl)disulfanyl)pentanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid |
94 |
h |
2024-12-25 |
70674 |
mPEG7-NH2,甲氧基七聚乙二醇-氨基 |
113 |
wyh |
2024-12-25 |
70675 |
Zn-5,10,15,20-四(4-羧基苯基)卟啉(TCPP-Zn) |
116 |
WYQ |
2024-12-25 |
70676 |
N3-PEG4-C2-Pfp ester,1353012-00-6,抗体- 药物偶联物 |
67 |
hyy |
2024-12-25 |
70677 |
cas:341498-08-6,N-Succinimidyl 4-(2-pyridyldithio)pentanoate |
92 |
h |
2024-12-25 |
70678 |
mPEG16-NH2 ,cas:907577-50-8 ,甲氧基十六聚乙二醇-氨基 |
101 |
wyh |
2024-12-25 |
70679 |
cas:115088-06-7,N-Succinimidyl 4-(2-pyridyldithio)butanoate |
97 |
h |
2024-12-25 |
70680 |
mPEG48-Br,甲氧基四十八聚乙二醇溴代 |
76 |
wyh |
2024-12-25 |
70681 |
四价锰四苯基卟啉配合物,[XMnⅣ)TPP]2O(X=N3-或OCN-) |
99 |
WYQ |
2024-12-25 |
70682 |
mPEG11-Br,溴代十一甘醇单甲醚 |
66 |
wyh |
2024-12-25 |
70683 |
NHS-PEG4-azide,叠氮-PEG4-NHS酯,944251-24-5 ,ADC试剂 |
78 |
hyy |
2024-12-25 |
70684 |
cas:1610769-13-5,4-((S)-2-((S)-2-amino-3- methylbutanamido)-5- ureidopentanamido)benzyl 2-(pyridin- 2-yldisulfanyl)ethylcarbamate |
88 |
h |
2024-12-25 |
70685 |
mPEG4-OCH2COOH的结构特点,16024-66-1 |
99 |
wyh |
2024-12-25 |
70686 |
5,10,15,20-四-(对-十二酰氧基)苯基卟啉 (TLPPH2) |
68 |
WYQ |
2024-12-25 |
70687 |
四苯基钯卟啉(Pd TPP),卟啉类化合物 |
157 |
WYQ |
2024-12-25 |
70688 |
N3-PEG3-C2-NHS ester,1245718-89-1,抗体- 药物偶联物 |
76 |
hyy |
2024-12-25 |
70689 |
cas:2353409-52-4 Mal-amido-PEG8-val-gly-PAB-OH |
54 |
h |
2024-12-25 |
70690 |
mPEG24-NH-Mal ,甲氧基二十四聚乙二醇-NH-马来酰亚胺 |
69 |
wyh |
2024-12-25 |
70691 |
cas:330970-70-2 Alloc-Val-Ala-OH,抗体偶联药物 |
70 |
h |
2024-12-25 |
70692 |
mPEG3-SH ,甲氧基三聚乙二醇-巯基 |
87 |
wyh |
2024-12-25 |
70693 |
cas:150114-97-9 Fmoc-Val-Ala-OH,抗体偶联药物 |
91 |
h |
2024-12-25 |
70694 |
N3-PEG2-C2-NHS ester,1312309-64-0,ADC试剂 |
69 |
hyy |
2024-12-25 |
70695 |
Methyltetrazine-CH2NHCO-PEG12-CH2CH2NH2 |
61 |
zyl |
2024-12-25 |